It was good news for generic drug firms such as Allergan (AGN) and Mylan (MYL), as pharma giant Pfizer (PFE) lost a long legal battle in Britain regarding the patents … Continue reading Allergan, Mylan and other generics beam as Pfizer loses patent war in the UK